Press release
Moderate to Severe Acne Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ascletis Pharma, Botanix, Biofrontera, Novartis, Biopharmx, Dermata, AnaptysBio, VYNE Therapeutics
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Moderate to Severe Acne therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years."Moderate to Severe Acne Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Moderate to Severe Acne Therapeutics Market.
The report provides a detailed description of the Moderate to Severe Acne drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Moderate to Severe Acne Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/moderate-to-severe-acne-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Moderate to Severe Acne Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Moderate to Severe Acne therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Moderate to Severe Acne treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Moderate to Severe Acne drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Moderate to Severe Acne treatment market.
Learn More about the Clinical and Commercial Development Activities in the Moderate to Severe Acne Therapeutics Domain @
https://www.delveinsight.com/report-store/moderate-to-severe-acne-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Moderate to Severe Acne Therapeutics Analysis
There are approx. 10+ key companies developing therapies for Moderate to Severe Acne. Currently, Ascletis Pharma Inc is leading the therapeutics market with its Moderate to Severe Acne drug candidates in the most advanced stage of clinical development.
Moderate to Severe Acne Companies in the Therapeutics Market Include:
• Ascletis Pharma Inc.
• Botanix Pharmaceuticals
• Biofrontera Bioscience GmbH
• Novartis
• BIOPHARMX, INC.
• DERMATA THERAPEUTICS, INC
• AnaptysBio
• VYNE Therapeutics Inc.
And Many Others
Emerging and Marketed Moderate to Severe Acne Therapies Covered in the Report Include:
• ASC40: Ascletis Pharma Inc.
• BTX 1503: Botanix Pharmaceuticals
And Many More
Get an in-depth Assessment of the Emerging Therapies and Moderate to Severe Acne Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/moderate-to-severe-acne-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Moderate to Severe Acne Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Moderate to Severe Acne pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types such as
Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Request for Sample PDF to Understand More About the Moderate to Severe Acne Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/moderate-to-severe-acne-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Moderate to Severe Acne Current Treatment Patterns
4. Moderate to Severe Acne - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Moderate to Severe Acne Late-Stage Products (Phase-III)
7. Moderate to Severe Acne Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Moderate to Severe Acne Discontinued Products
13. Moderate to Severe Acne Product Profiles
14. Moderate to Severe Acne Companies
15. Moderate to Severe Acne Drugs
16. Dormant and Discontinued Products
17. Moderate to Severe Acne Unmet Needs
18. Moderate to Severe Acne Future Perspectives
19. Moderate to Severe Acne Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/moderate-to-severe-acne-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Schizophrenia Market
https://www.delveinsight.com/report-store/schizophrenia-market
Human Immunodeficiency Virus Type-1 (HIV-1) Market
https://www.delveinsight.com/report-store/human-immunodeficiency-virus-type-1-hiv-1-market
US Healthcare Outlook Bulimia Nervosa Market
https://www.delveinsight.com/report-store/bulimia-nervosa-market
Hepatitis B Virus (HBV) Infection Market
https://www.delveinsight.com/report-store/hepatitis-b-virus-hbv-infection-market
Pancreatic Cancer Market
https://www.delveinsight.com/report-store/pancreatic-cancer-market
Hepatitis C Market
https://www.delveinsight.com/report-store/hepatitis-c-market
Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market
Cytomegalovirus (CMV) Infections Market
https://www.delveinsight.com/report-store/cytomegalovirus-cmv-infection-market-insight-epidemiology-and-market-forecast
Spinal Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-fusion-devices-market
Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
Giant-Cell Arteritis Market
https://www.delveinsight.com/report-store/giant-cell-arteritis-market
Traveler's Diarrhea Market
https://www.delveinsight.com/report-store/travelers-diarrhea-market
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
Patent Foramen Ovale (PFO) Closure Devices Market
https://www.delveinsight.com/report-store/patent-foramen-ovale-closure-devices-market
Invasive Pneumococcal Disease Market
https://www.delveinsight.com/report-store/invasive-pneumococcal-disease-market
Echocardiography Devices Market
https://www.delveinsight.com/report-store/echocardiography-devices-market
Primary Immune Deficiency (PID) Market
https://www.delveinsight.com/report-store/primary-immune-deficiency-pid-market
Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market
Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market
Postoperative Nausea and Vomiting (PONV) Market
https://www.delveinsight.com/report-store/postoperative-nausea-and-vomiting-ponv-market
Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market
Hemodynamic Monitoring Systems Market
https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
Peripheral Neuritis Market
https://www.delveinsight.com/report-store/peripheral-neuritis-market
Food Allergy Market
https://www.delveinsight.com/report-store/food-allergy-market-insights
Embolotherapy Market
https://www.delveinsight.com/report-store/embolotherapy-market
Psychosis Market
https://www.delveinsight.com/report-store/psychosis-market
Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
Spinal Non-Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-non-fusion-devices-market
Corneal Dystrophy Market
https://www.delveinsight.com/report-store/corneal-dystrophy-market
Myasthenia Gravis Market
https://www.delveinsight.com/report-store/myasthenia-gravis-market
Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market
Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market
Injectable Drug Delivery Devices Market
https://www.delveinsight.com/report-store/injectable-drug-delivery-devices-market
Atherectomy Devices Market
https://www.delveinsight.com/report-store/atherectomy-devices-market
Chemotherapy Induced Nausea and Vomiting Market
https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-market
Structural Heart Devices Market
https://www.delveinsight.com/report-store/structural-heart-devices-market-market
Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market
Tissue Heart Valves Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market
Cardiovascular Prosthetic Devices Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market
Diabetic Macular Edema (DME) Market
https://www.delveinsight.com/report-store/diabetic-macular-edema-dme-market
End-Stage Renal Disease (ESRD) Market
https://www.delveinsight.com/report-store/end-stage-renal-disease-esrd-market
Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
Renal Insufficiency Market
https://www.delveinsight.com/report-store/renal-insufficiency-market
Diabetic Retinopathy Market
https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Artificial Cornea and Corneal Implant Market
https://www.delveinsight.com/report-store/artificial-cornea-and-corneal-implant-market
Herpes Simplex Market
https://www.delveinsight.com/report-store/herpes-simplex-market
Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Moderate to Severe Acne Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ascletis Pharma, Botanix, Biofrontera, Novartis, Biopharmx, Dermata, AnaptysBio, VYNE Therapeutics here
News-ID: 3281329 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Moderate
Synchronous Condenser Market Set for Moderate Growth by 2030
According to a new report published by Allied Market Research, The synchronous condenser market size was valued at $568.9 million in 2020, and is projected to reach $751 million by 2030, growing at a CAGR of 2.8% from 2021 to 2030.
Synchronous condenser is the device used to generate or absorb reactive power as per the need for stabilization of electric utilities. It is an alternative to capacitor bank to correct…
Tin Market Outlook: Moderate Growth Projected Through 2032
Tin Market size was valued at 282.52 Kilotonin 2024 and the total Tin revenue is expected to grow at a CAGR of 2.1% from 2025 to 2032, reaching nearly 333.63 Kiloton.
Tin Market Overview:
The tin market is witnessing consistent growth due to its critical applications across several industries. Tin is most commonly used in soldering, particularly within the electronics industry, which continues to expand with the rise of consumer electronics, renewable…
Biocides Market Forecast Shows Moderate but Consistent Growth
Biocides market is expected to reach US$ 16.07 Bn. in 2030 from US$ 12.30 Bn. in 2023, with a CAGR of 3.9% for the period 2024-2030.
Biocides Market Overview:
The biocides market is experiencing steady growth, driven by increasing demand across various industries such as water treatment, healthcare, agriculture, and consumer goods. Biocides, which are chemical or biological agents that control harmful organisms, play a crucial role in ensuring hygiene, preserving materials,…
Dutch Mendenhall to Moderate Athletes in Business Panel
Las Vegas, NV - July 9, 2024 - Dutch Mendenhall [https://www.linkedin.com/in/dutchmendenhall], the esteemed owner of Wentworth Golf Club [https://wentworthgolfclub.org/], best-selling author of Money Shackles, and former Division 1 volunteer coach, will moderate the "Athletes in Business" panel at The Palms Las Vegas on Sunday, July 14, 2024. This event will bring together some of the most influential athletes turned business professionals to share their insights and experiences.
Dutch Mendenhall's diverse background…
Planter Market will reflect a relatively moderate growth in demand
Planter is a container used for planting flowers, and different types of small plants. It can be of plastic, wood, ceramics, and glass. Planters are of different sizes, shapes, and colors. These are mostly used for decoration, nurseries, and greenhouses for both interior as well as exterior decoration. These help enhance the appearance of the property. The use of planter in decoration in hotels, rental houses can attract the customer.
…
Mild-to-Moderate Atopic Dermatitis Treatment Market: Lucrative Opportunities
Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often localized to the flexural surfaces of the body and usually begins in childhood. This skin disease affects a large percentage of the world's population. Atopic dermatitis, commonly known as eczema, is characterized by dry skin, itching, redness, swelling, vesicle formation, cracking, weeping, crusting, and scaling. Atopic dermatitis is a long-term skin disease, which is classified into different types depending on…